Snowball logo
logo
BAYN_logo

Bayer Aktiengesellschaft

48.06+0.06  (0.13%)
Estimate
EPS
-1.76
Beta
0.833
Growth
Revenue, YoY
-2.42%
Net income, YoY
112.7%
FCF, YoY
-65.36%
Forecast
P/E (FWD)
10.2
EPS (FWD)
4.726
Dividends
Dividend yield
0.23%
Annual payout
0.11
Next ex. div date
April 27, 27
Div.growth, 5y
-47.66%
Div.rating
About the company
Ticker
BAYN
ISIN
DE000BAY0017
Country
Germany
Sector (GICS)
Healthcare
Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers nonprescription over-the-counter medicines for self-medication and self-care; nutritional supplements; allergy, cough, and cold; dermatology; pain and cardiovascular risk prevention; and digestive health products. The Crop Science segment offers chemical and biological crop protection products, improved plant traits, seeds, digital solutions, and pest and weed management products, as well as customer services for agriculture. It also engages in the breeding, propagation, and production/processing of seeds, including seed dressing. The company distributes its products through wholesalers, pharmacies and pharmacy chains, supermarkets, online and other retailers, and hospitals, as well as directly to farmers. Bayer Aktiengesellschaft has a strategic alliance with The University of Colorado Anschutz, along with UCHealth and Children's Hospital Colorado to advance drug development and clinical trials. Bayer Aktiengesellschaft has a strategic alliance Henry Ford Health. Bayer Aktiengesellschaft was founded in 1863 and is based in Leverkusen, Germany.

Frequently asked questions

What sector does Bayer Aktiengesellschaft (BAYN) operate in?

Bayer Aktiengesellschaft belongs to the Healthcare sector and operates in the Drug Manufacturers - General industry.

What is Bayer Aktiengesellschaft (BAYN) current stock price?

As of the latest data, Bayer Aktiengesellschaft stock price is €48.06, with a previous close of €48.00. Bayer Aktiengesellschaft gained €0.06 in the last trading session, representing a 0.13% increase.

What is Bayer Aktiengesellschaft (BAYN) current market capitalization?

Bayer Aktiengesellschaft market cap is approximately 47.22 billion.

What is Bayer Aktiengesellschaft (BAYN) Earnings Per Share (EPS)?

The trailing EPS is -€1.76, and the forward EPS is €4.73.

What is Bayer Aktiengesellschaft (BAYN) EBITDA?

Bayer Aktiengesellschaft EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 4.92 billion.

Does Bayer Aktiengesellschaft (BAYN) pay dividends?

Yes. Bayer Aktiengesellschaft pays annual dividends with an annualized yield of 0.23% and an estimated annual payout of €0.11 per share.

When is the next ex-dividend date for Bayer Aktiengesellschaft (BAYN)?

The next ex-dividend date is scheduled for April 27, 2027.

How did Bayer Aktiengesellschaft (BAYN) perform in its most recent earnings report?

In the last report (June 30, 2026), Bayer Aktiengesellschaft posted an EPS surprise of 25.18% and a revenue surprise of -0.82%.

When is Bayer Aktiengesellschaft (BAYN) next earnings report?

Bayer Aktiengesellschaft is expected to release its next earnings report on September 30, 2026.

What is Bayer Aktiengesellschaft (BAYN) beta (volatility) score?

Bayer Aktiengesellschaft has a beta of 0.833, meaning its volatility is roughly in line with the market.